A new approach to treating neuroblastoma that could enable therapy with fewer side-effects has been heralded as "promising" by experts. Researchers from the University of Cambridge said their ...

Please provide your email address to receive an email when new articles are posted on . Determining risk classifications of children with neuroblastoma is “paramount” to optimizing their care, the ...

The derivative slowed tumor growth, shrunk tumors, and extended the life of the mice. Researchers at Duke Medicine have identified a new strategy for treating neuroblastoma using a modified version of ...

Neuroblastoma is a common pediatric cancer that originates in developing nerve cells outside the brain. While increasingly intensive treatments have improved the survival of patients with high-risk ...

An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent the longest reported remission to date in a patient treated with chimeric ...

Children with a rare form of cancer called neuroblastoma which hasn't responded to initial treatment or that has relapsed may benefit from adding antibody treatment to usual chemotherapy, according to ...

(L to R) Co-first and co-corresponding author Min Pan, PhD, co-first author Yinwen Zhang, PhD, St. Jude Department of Computational Biology, co-corresponding author John Easton, PhD, St. Jude ...

A research team from the University of Zurich and the University Children's Hospital Zurich has developed a new approach for treating children with malignant tumors of the nervous system. By combining ...

Neuroblastomas are the most common cancer in infants, with about 700–800 diagnoses per year in the US, according to the American Cancer Society. Some of the most high-risk cases are driven by elevated ...

Childhood neuroblastoma is often a fatal disease. Despite initial treatment success, most patients relapse or develop resistance to the current therapies. A new approach using a combination of two ...

ATLANTA - When Edward Page got sick back in the fall of 2017, his parents, Jinnie and Andrew say things unraveled quickly. "He'd had about a month of random fevers, abdominal pain, some weight loss," ...

The MYCN oncoprotein plays a key role in starting, advancing and making it difficult to treat various human cancers. When MYCN is overactive, especially in high-risk neuroblastoma, the tumors become ...